Physician profile
Peter Vosler
NPI 1215222518
$3,630.66
in general payments reported to CMS, 2019-2025
14 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $98.79 · 2023: $522 · 2024: $985 · 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,402 · Travel and Lodging: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,402.00 |
| Travel and Lodging | $550.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,341.60 | 2023-2025 | Inspire |
| Stryker Corporation | $843.41 | 2020-2025 | Na |
| Medtronic, INC. | $298.98 | 2024 | Pteye Parathyroid Detection System, Fusion |
| Baxter Healthcare | $278.98 | 2019-2024 | Tisseel |
| Intuitive Surgical, INC. | $210.99 | 2019-2025 | |
| Depuy Synthes Sales INC. | $174.79 | 2019 | |
| Axogen | $173.41 | 2023 | Avance Nerve Graft |
| Acera Surgical, INC. | $133.74 | 2025 | Restrata Wound Matrix |
| Freudenberg Medical, LLC | $64.56 | 2023 | |
| Surgenex LLC | $31.54 | 2025 | Ardeograft, Pellograft, Surmatrix |
| Polymedics Innovations INC. | $27.31 | 2024 | |
| Integra Lifesciences Corporation | $21.75 | 2023 | Integra Duo, Instruments-Orthopedic, Codman Isocool Aht |
| Ambu INC. | $15.62 | 2024 | |
| Olympus America INC. | $13.98 | 2024 | Olympus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Vosler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.